Exploratory/Developmental Bioengineering Research Grants (EBRG)
National Institutes of Health (NIH)
Total budget: $275,000 over a maximum of 2 years
No more than $200,000 in any single year
To encourage submissions of exploratory/developmental Bioengineering Research Grant applications.
To demonstrate feasibility and potential utility of new capabilities or improvements in biomedical research.
Biomedical researchers
Healthcare providers
Patients and communities benefiting from improved biomedical solutions
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, and various levels of government.
Specific qualifications include having the skills, knowledge, and resources necessary to carry out the proposed research.
Eligible organizations can be based in the U.S. or be foreign organizations.
Non-domestic components of U.S. organizations are also eligible.
Projects must demonstrate feasibility and potential utility of new capabilities.
Research may include hypothesis-driven, discovery-driven, developmental, or design-directed approaches.
Total direct costs for the two-year project period may not exceed $275,000.
No more than $200,000 may be requested in any single year.
Application due date: January 7, 2028.
Projects must be completed within a maximum of 2 years.
Applicants may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or overlapping applications under review at the same time.
Applications must follow the instructions in the How to Apply - Application Guide.
Specific forms and templates must be used as outlined in the application instructions.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise of the investigators.
Applications will undergo peer review and will be evaluated for scientific and technical merit.
Applications will compete for available funds based on scientific merit and relevance to program priorities.
Projects must not propose clinical trials.
Applications that do not demonstrate feasibility or potential utility may be considered nonresponsive.
Projects may face risks associated with feasibility tests and early development.
Encourages multidisciplinary approaches to biomedical challenges.
Innovative approaches may provide a competitive edge in addressing biomedical problems.
Demonstrating the significance and potential impact of the proposed work.
Submitting applications that do not comply with the application instructions.
Engage in multidisciplinary collaborations to enhance project feasibility.
Highlight innovative aspects of the proposed research to stand out in the review process.